drugset / Trial / NCT00575367

Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers

NCT00575367

Phase 4 Completed 37 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the drug concentrations of AzaSite compared to Vigamox in tears of healthy volunteers

Timeline

Start
2008-03
Primary completion
2008-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule Other
Comparator Moxifloxacin Small molecule Other